Retention in Care and Outpatient Costs for Children Receiving Antiretroviral Therapy in Zambia: A Retrospective Cohort Analysis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Scott, Callie A ^a,b   Iyer, Hari ^b   Bwalya, Deophine Lembela ^b   McCoy, Kelly ^a   Meyer Rath, Gesine ^a,c   Moyo, Crispin ^d   Bolton Moore, Carolyn ^e,f   Larson, Bruce ^a,g   Rosen, Sydney ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b Zambia Center for Applied Health Research and Development   (Zambia)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d MINISTRY OF HEALTH   (Zambia)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^g BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS STAVUDINE;

ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CHILD CARE; COHORT ANALYSIS; DRUG COST; FOLLOW UP; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RECORD REVIEW; OUTPATIENT CARE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ZAMBIA;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; HEALTH CARE COSTS; HUMANS; INFANT; INFANT, NEWBORN; MEDICAL LABORATORY SCIENCE; OUTPATIENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ZAMBIA;

EID: 84879545221     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067910     Document Type: Article

References (19)

1. World Health Organization (2011) Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf. Accessed: 3 September 2012.
2. Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV, et al. (2009) Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis 49: 1915-1927.
3. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, et al. (2007) Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 298: 1888-1899.
4. van Dijk JH, Sutcliffe CG, Munsanje B, Sinywimaanzi P, Hamangaba F, et al. (2011) HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS One 6: e19006.
5. Galarraga O, Wirtz VJ, Figueroa-Lara A, Santa-Ana-Tellez Y, Coulibaly I, et al. (2011) Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics 29: 579-599.
6. Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, et al. (2011) The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS 25: 1753-1760.
7. Marques HH, Couttolenc BF, Latorre Mdo R, Aquino MZ, Aveiro MI, et al. (2007) Costs of care provided in a university hospital for children exposed to or infected with the HIV/AIDS. Cad Saude Publica 23Suppl 3: S402-413.
8. Meyer-Rath G, Brennan A, Long L, Ndibongo B, Technau K, et al. (2013) Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS 27: 243-250.
9. Rosen S, Long L, Sanne I, (2008) The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health 13: 1005-1015.
10. Long L, Fox M, Sanne I, Rosen S, (2010) The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS 24: 915-919.
11. Government of the Republic of Zambia, Ministry of Health (2007) Zambian guidelines for antiretroviral therapy of HIV infection in infants and children: towards universal access, 2007. Available: http://www.who.int/hiv/amds/zambia_paediatric_guidelines_2007.pdf. Accessed 3 September 2012.
12. International Monetary Fund (2012) World Economic Outlook Database, April 2012. Available: http://www.imf.org/external/pubs/ft/weo/2012/01/weodata/index.aspx. Accessed 3 September 2012.
13. Oanda Corporation (2012) Historical exchange rates: daily midpoint rates: January 1, 2011 to December 31, 2011. Available: www.oanda.com/currency/historical-rates/. Accessed 2 March 2012.
14. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, (1996) Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276: 1253-1258.
15. World Health Organization (2011) Global price reporting mechanism. Available: http://www.who.int/hiv/amds/gprm/en/. Accessed 22 March 2012.
16. Government of the Republic of Zambia, Ministry of Health. Medical Stores Limited: 2010 catalogue. Lusaka, Zambia: Government of the Republic of Zambia, Ministry of Health; 2010.
17. Bratt JH, Torpey K, Kabaso M, Gondwe Y, (2011) Costs of HIV/AIDS outpatient services delivered through Zambian public health facilities. Trop Med Int Health 16: 110-118.
18. Tagar E, Sundaram M, Condliffe K, Over M, Assefa Y,et al. The cost of scaling-up antiretroviral treatment: a costing study in 161 representative facilities in Ethiopia, Malawi, Rwanda and Zambia [abstract THPE738]; XIX International AIDS Conference, 22-27 July 2012; Washington, DC, USA.
19. Marseille E, Giganti MJ, Mwango A, Chisembele-Taylor A, Mulenga L, et al. (2012) Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia. PLoS One 7: e51993.